22nd Aug 2019 11:49
(Alliance News) - IXICO PLC said Thursday Chief Financial Officer Grant Nash has joined the board of the neuroscience-focused data analytics firm, whilst Non-Executive Director Tim Sharpington prepares to leave at the end of September.
Nash was appointed finance chief in late April, joining IXICO from the health research data organisation UK Biobank. He will now join the board with immediate effect.
IXICO Chief Executive Officer Giulio Cerroni said the appointment of Nash to the board "reflects the substantial contribution he has already made to IXICO since his appointment as CFO. He has brought strong financial leadership skills combined with a deep appreciation of operational excellence at a time of significant revenue growth and an accelerated path to profitability."
Sharpington - non-executive since 2013 - intends to stand down from IXICO at the end of the financial year at the end of September in order to "focus on his executive responsibilities elsewhere."
"Since its admission to AIM in 2013, he has guided and supported IXICO through a number of strategic challenges and changes," IXICO Chair Charles Spicer said. "In that time, the company has significantly enhanced its position in providing specialist data analytics for neuroscience drug development and more than doubled revenues over the last three years. We all wish him well for his future endeavours."
Shares in IXICO were 3.1% higher at 58.78 pence in London on Thursday.
Related Shares:
Ixico